ABPI response to meeting between industry and Government on HRT supply
The ABPI welcomed today’s meeting between industry and Government on HRT supply.
The shortage of some HRT products is a complex problem, and continued collaboration between Government, industry and the NHS is an important part of the solution. Richard Torbett, Chief Executive, ABPI
Chief Executive Richard Torbett said:
“Recent Government and media-led campaigns are incredibly important in helping women understand the benefits of HRT and get the medicines they need to support them.
“The shortage of some HRT products is a complex problem, and continued collaboration between Government, industry and the NHS is an important part of the solution.
“Intelligence sharing to determine demand is absolutely crucial, and will allow companies to take action to maintain supply wherever possible.
“Removing restrictions on prescribing of products in local areas could also prevent local variation in care and in prescribing practice, which in turn means medicines are less likely to run out of stock.
“Taken together, this should help smooth supply and demand, and help patients access treatments.”
- Supply
Last modified: 20 September 2023
Last reviewed: 20 September 2023